Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805059 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT05805059 is a NA study that has completed, run by CooperVision. The registered enrollment target is 68 participants.
The verdict
NCT05805059, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.
Interventions
- DEVICE Control Contact Lens (stenfilcon A)
- DEVICE Test Contact Lens (senofilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2023-04-14 |
| Est. Completion | 2023-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05805059
The ClinicalTrials.gov registry entry for NCT05805059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Contact Lens (stenfilcon A) is the first listed.
NCT05805059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05805059 about?
NCT05805059 is a clinical study titled "Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses". The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.
What is the current status of trial NCT05805059?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2023-04-14. Estimated completion is 2023-06-20.
What interventions are being tested in trial NCT05805059?
The interventions under investigation include: Control Contact Lens (stenfilcon A) (DEVICE), Test Contact Lens (senofilcon A) (DEVICE).
Who is sponsoring clinical trial NCT05805059?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.